Vireo Growth Inc. (VREOF): M&A transaction — Vireo Growth closes acquisition of Schwazze's 45 dispensaries and 2 manufacturing facilities

Vireo Growth Inc.

Acquired 24 Colorado dispensaries, 21 New Mexico dispensaries, and one manufacturing facility in each state.
Implied estimated valuation under 4x pro forma EBITDA; credit bid of ~$111M in Senior Secured Notes.
Justin Dye appointed Chairman of Colorado/New Mexico business; Forrest Hoffmaster named CEO of those operations.
NewCo entered into $50M Tranche A and $12.7M Tranche B term loans; CO Acquisition closed $26M facility.
Transaction expands Vireo's retail footprint to over 75 dispensaries in Colorado and New Mexico over time.

item 1.01 item 2.01 item 2.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Vireo Growth Inc. completed an acquisition involving Medicine Man Technologies, Inc. d/b/a Schwazze for $111 million credit bid (closed 2026-03-19).

Action: acquisition
Counterparty: Medicine Man Technologies, Inc. d/b/a Schwazze
Consideration: $111 million credit bid
Closing: 2026-03-19

Exact text from the filing

of Schwazze’s collateral was completed, and the collateral agent under the indenture governing the Senior Secured Notes, acting at the direction of VHC, credit bid approximately $111 million principal amount of Senior Secured Notes on behalf of VHC and other noteholders (the “ Credit Bid ”). The Credit Bid was determined to be the winning bid upon conclusion of the

View on SEC.gov

Browse all m&a transactions →

Vireo Growth Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-034509

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.